Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Atridia Pty Ltd.
Scientific Title
An Open-label, Multicenter, Non-randomized, Dose Escalation Phase 1 Trial to Evaluate Safety and Tolerability of SHR-1210 in Patients With Advanced Solid Tumors